| Name | Title | Contact Details |
|---|
Egg Donation & Gestational Surrogacy services. Since 1996 ConceiveAbilities has professionally partnered with countless physicians and intended parents around the globe to help build families via third party reproduction. More than 20 years navigating the infertility industry has positioned ConceiveAbilities as the best partner to provide an unmatched level of service. Our unique and extensive experience and a reputation built on unparalleled service, knowledge and communication, allows us to cultivate excellent professional relationships with doctors and clinics, in addition to providing our clients, egg donors and surrogates with consistently solid service. Here at ConceiveAbilities, we believe that individuals and couples who have the desire to pursue a family, deserve the best support and resources possible. If you are committed to excellence and would like to join our team of enthusiastic dream-makers, we invite you to browse our webpage highlighting open positions among ConceiveAbilities` multiple locations.
Xcelience, LLC is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Tampa, FL. To find more information about Xcelience, LLC, please visit www.xcelience.com
LifeWatch is the nation?s leading ambulatory health monitoring services company.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Canadian Health and Lifestyle Magazine is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.